Adendra Therapeutics

Adendra Therapeutics is a discovery-stage biotechnology company developing small molecule and biologic medicines targeting dendritic cell biology for the treatment of solid tumours and autoimmune diseases.

The company's approach is based on research into how dendritic cells regulate adaptive immune responses to cell death, with the aim of augmenting or suppressing immune activity depending on the disease context.

Adendra was founded as a spinout of the Francis Crick Institute.